vida: extract claims from 2026-04-28-phti-employer-glp1-coverage-behavioral-mandate-2025

- Source: inbox/queue/2026-04-28-phti-employer-glp1-coverage-behavioral-mandate-2025.md
- Domain: health
- Claims: 2, Entities: 0
- Enrichments: 5
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>

domains/health/digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring.md

@@ -39,3 +39,10 @@ Omada Health's 3x growth in GLP-1 members over 12 months (reaching 150K members)
 **Source:** Omada Health clinical data, JMIR publication
 
 Omada's Enhanced GLP-1 Care Track achieved 67% persistence at 12 months versus 47-49% for standard care, representing a 20-percentage-point improvement. This data is from JMIR-published research and is now validated at commercial scale with 150K+ members in the GLP-1 track as of early 2026.
+
+
+## Extending Evidence
+
+**Source:** PHTI December 2025 employer report
+
+34% of employers now mandate behavioral support as a coverage condition (up from 10%), and three major payers (Evernorth, Optum Rx, UHC) have operationalized behavioral support as prerequisite infrastructure. This represents market-wide validation that behavioral support improves persistence enough to justify mandatory implementation at the payer level.

domains/health/glp1-behavioral-mandate-rate-tripled-2024-2025-signaling-managed-access-infrastructure-shift.md

@@ -0,0 +1,19 @@
+---
+type: claim
+domain: health
+description: Employer coverage of GLP-1s now predominantly requires behavioral support as a prerequisite, not an optional add-on, representing a fundamental change in payer strategy
+confidence: likely
+source: Peterson Health Technology Institute, December 2025 employer market trend report
+created: 2026-04-28
+title: "GLP-1 behavioral support mandates tripled in one year (10% to 34%) signaling structural shift from drug-only formulary to managed-access operating systems"
+agent: vida
+sourced_from: health/2026-04-28-phti-employer-glp1-coverage-behavioral-mandate-2025.md
+scope: structural
+sourcer: Peterson Health Technology Institute
+supports: ["glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024"]
+related: ["glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024", "value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk", "comprehensive-behavioral-wraparound-enables-durable-weight-maintenance-post-glp1-cessation", "digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring", "glp1-year-one-persistence-doubled-2021-2024-supply-normalization", "glp-1-therapy-requires-nutritional-monitoring-infrastructure-but-92-percent-receive-no-dietitian-support"]
+---
+
+# GLP-1 behavioral support mandates tripled in one year (10% to 34%) signaling structural shift from drug-only formulary to managed-access operating systems
+
+PHTI's December 2025 employer survey found that 34% of firms covering GLP-1s now require dietitian, case management, therapy, or lifestyle participation as a coverage condition, up from 10% the prior year—a 3.4x increase in 12 months. This is not incremental adoption but structural acceleration. Three major payers have operationalized this shift: Evernorth EncircleRx (9M lives, $200M saved since 2024), Optum Rx Weight Engage (coaching + specialist navigation), and UHC Total Weight Support (mandates Real Appeal Rx or WeightWatchers as coverage prerequisite). The mandate rate acceleration coincides with 77% of large employers rating GLP-1 cost management as 'extremely or very important' for 2026, and 59% reporting utilization exceeding expectations. The shift is driven by economic necessity: 36.2M eligible commercially insured adults × $1,000-1,200/month creates fiscal unsustainability under traditional yes/no formulary logic. Payers are building what PHTI calls 'managed-access operating systems' covering population qualification, channel routing, behavioral gates, subsidy levels, and discontinuation rules. This is infrastructure, not incremental policy adjustment.

domains/health/glp1-long-term-persistence-ceiling-14-percent-year-two.md

@@ -65,3 +65,10 @@ Meta-regression data cited by on/healthcare.tech shows ~50% discontinuation with
 **Source:** Nicholas Thompson LinkedIn 2026; cross-reference to digital-behavioral-support-improves-glp1-persistence-20-percentage-points
 
 The $1.8B, 2-person AI-staffed GLP-1 telehealth startup demonstrates that low-end commoditization (prescribing-only, no behavioral support) is already occurring at massive scale. However, this pure-prescribing model likely faces even worse persistence rates than the 14% year-two ceiling, since behavioral support is known to improve GLP-1 persistence by 20 percentage points. The startup's legal issues (FDA warnings, lawsuits over AI-generated patient photos) suggest that AI-only prescribing without behavioral wraparound creates both clinical and legal risks that may limit long-term viability despite short-term revenue growth.
+
+
+## Supporting Evidence
+
+**Source:** PHTI December 2025 employer report citing Prime Therapeutics
+
+Prime Therapeutics data cited in PHTI report confirms only 1-in-12 patients (8.3%) remain on therapy after three years, which is even lower than the 14% year-two ceiling. This provides independent corroboration from a major PBM dataset.

domains/health/glp1-managed-access-infrastructure-creates-distinct-platform-opportunity-beyond-behavioral-coaching.md

@@ -0,0 +1,18 @@
+---
+type: claim
+domain: health
+description: The payer response to GLP-1 economics requires multi-component infrastructure (utilization management, adherence systems, indication-specific programs, discontinuation protocols) that functions as an operating system, not just a coaching add-on
+confidence: experimental
+source: Peterson Health Technology Institute, December 2025 employer market trend report
+created: 2026-04-28
+title: GLP-1 managed-access infrastructure layer creates a distinct platform opportunity separate from behavioral coaching
+agent: vida
+sourced_from: health/2026-04-28-phti-employer-glp1-coverage-behavioral-mandate-2025.md
+scope: structural
+sourcer: Peterson Health Technology Institute
+related: ["glp1-behavioral-mandate-rate-tripled-2024-2025-signaling-managed-access-infrastructure-shift", "glp1-managed-access-operating-systems-require-multi-layer-infrastructure-beyond-formulary", "glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024"]
+---
+
+# GLP-1 managed-access infrastructure layer creates a distinct platform opportunity separate from behavioral coaching
+
+PHTI identifies five infrastructure components required for managed GLP-1 access: (1) utilization management infrastructure, (2) outcomes-based contracting frameworks, (3) indication-specific cardiometabolic programs (CVD, OSA, MASH, perimenopause, prediabetes), (4) adherence, tapering, and discontinuation management systems, and (5) employer-side financing or subsidy products. This is architecturally distinct from behavioral coaching. The report describes payers building 'managed-access operating systems' that determine which populations qualify, through which channels, with what behavioral gates, at what subsidy levels, and with what discontinuation rules. This is not a feature—it's a platform. The infrastructure layer exists because traditional yes/no formulary decisions cannot accommodate GLP-1 economics (36.2M eligible × $1,000-1,200/month). Three major payers (Evernorth, Optum Rx, UHC) have operationalized distinct infrastructure plays, not just coaching partnerships. The platform opportunity is separate from the behavioral coaching layer because it operates at the payer-employer interface, not the patient-provider interface.

domains/health/glp1-managed-access-operating-systems-require-multi-layer-infrastructure-beyond-formulary.md

@@ -31,3 +31,10 @@ Payers are responding by building managed-access operating systems with distinct
 The persistence problem justifies this infrastructure investment: meta-regression data shows ~50% discontinuation within one year, ~60% weight regain within 12 months of cessation, and only 1-in-12 patients remaining on therapy at three years (Prime Therapeutics, cited by Mercer). Without behavioral gates, drug-only GLP-1 coverage is cost without durable benefit.
 
 Indication expansion creates additional complexity requiring distinct medical-necessity criteria and cost-offset narratives for each pathway. This is not a formulary problem — it's an operating system problem requiring continuous operational management.
+
+
+## Supporting Evidence
+
+**Source:** PHTI December 2025 employer report
+
+PHTI identifies five specific infrastructure components: utilization management, outcomes-based contracting, indication-specific programs, adherence/discontinuation systems, and employer financing products. Three major payers (Evernorth 9M lives, Optum Rx, UHC) have operationalized distinct infrastructure plays. 79% of large employers expanded utilization management despite flat obesity-indication coverage.

domains/health/manufacturer-direct-to-employer-channels-challenge-pbm-intermediation-through-price-compression.md

@@ -32,3 +32,10 @@ The durability of this model is uncertain (hence experimental confidence). Quest
 - How will PBMs respond — price matching, exclusion, or regulatory challenge?
 
 But the structural challenge is real: if manufacturers can profitably deliver GLP-1s at 55-60% below retail while providing behavioral support infrastructure, the PBM value proposition in this category is threatened.
+
+
+## Extending Evidence
+
+**Source:** PHTI December 2025 employer report
+
+Eli Lilly Employer Connect launched March 5, 2026 at $449/dose with partnerships across 15+ program administrators (GoodRx, Teladoc, Calibrate, Form Health, Waltz). Novo Nordisk launched parallel DTE with Waltz Health and 9amHealth on January 1, 2026. Both manufacturers are bundling behavioral support infrastructure into the DTE channel, not just offering price compression.

inbox/archive/health/2026-04-28-phti-employer-glp1-coverage-behavioral-mandate-2025.md

@@ -7,10 +7,13 @@ date: 2025-12-15
 domain: health
 secondary_domains: []
 format: report
-status: unprocessed
+status: processed
+processed_by: vida
+processed_date: 2026-04-28
 priority: high
 tags: [GLP-1, employer-benefits, payer-mandates, behavioral-support, value-based-care, adherence]
 intake_tier: research-task
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content